Print This Page

Home Chemicals Organic Chemicals Organic Intermediate

Tooth Regeneration Tideglusib Pharmaceutical Grade Tideglusib Powder Raw Material Tideglusib pictures & photos

Tooth Regeneration Tideglusib Pharmaceutical Grade Tideglusib Powder Raw Material Tideglusib

CAS No.:	865854-05-3
Formula:	C19h14n2o2s
EINECS:	N/M
Type:	Pharmaceutical Intermediates
Appearance:	Powder
Quality:	Tideglusib

Samples:	US$ 100/g 1 g(Min.Order) \| Request Sample

Customization:	Available \| Customized Request

Contact Supplier

Contact Now

Inquiry Basket

Xi`an Disheng Health Biotechnology Co., Ltd.

Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Manufacturer/Factory

Product Description

Company Info.

Overview
Product Description
Application&Function
Specification
Certifications
Packaging & Shipping

Basic Info.

Model NO.

D-sung-Tideglusib

Colour

White

Name

Tideglusib

Product Name

Tideglusib Powder

Character

White Powder

Melting Point

148-150oc

Boiling Point

511.3oc at 760 Mmhg

Refractive Index

1.735

Density

1.393

Grade

Pharmaceutical Grade

Application

Pharmaceutical

Assay

99%

Specific

COA

C19h14n2o2s

Test Method

HPLC UV

Shelf Life

2 Years

334.39

Transport Package

Negotiable

Specification

99%

Trademark

D-sung

Origin

Shaanxi

Production Capacity

5000kg/Month

Product Description

Tooth Regeneration Tideglusib Pharmaceutical grade Tideglusib powder Raw material Tideglusib

Product Name	Tideglusib
CAS NO.	865854-05-3
Purity	99%
Melting point	148-150 C
Appearance and shape	White powder

Tideglusib (NP-12, NP031112) is a potent, selective and irreversible small molecule non-ATP-competitive glycogen synthase kinase 3 (GSK-3) inhibitor.. Other GSK inhibitors. There are few classes of GSK-inhibitors, including lithium (Martinez et al., 2011), the small peptide L803mts10, and members of the thiazolidinedione family, containing non-competitive inhibitors of GSK-3, such as TDZD-8.Tideglusib is a GSK-3 inhibitor currently in phase II clinical trials for the treatment of Alzheimer disease and progressive supranuclear palsy.

Tooth Regeneration Tideglusib Pharmaceutical Grade Tideglusib Powder Raw Material Tideglusib Tideglusib was originally developed to treat Alzheimer's disease, but it was unexpectedly discovered that it can be used to regenerate damaged teeth. Tideglusib is an irreversible, non-ATP-competitive GSK-3β inhibitor with IC50 of 60 nM.On November 9, 2020, AMO pharma announced that the FDA has granted its investigational therapy AMO-02 (tideglusib) Rare Pediatric Disease (RPD) designation for the treatment of congenital myotonic dystrophy.